(Bloomberg) -- Investors are having an eventful day in drug-developer stocks after regulatory and manufacturing issues rocked a trio of high-flying companies on ...
Updated: 08/09/2019 11:39A
A strong July jobs report could sink Fed rate cut hopes and create more volatility for the Dow Jones, which has gotten a big Fed boost in 2019.
Updated: 02/25/2019 04:00A